A61K 31/422
Not condensed and containing further heterocyclic rings
Official title: not condensed and containing further heterocyclic rings
A61K31/422 (Not condensed and containing further heterocyclic rings) appears on 1,037 US grants and 1,795 published applications in this corpus.
Search patents in A61K- Granted patents
- 1,037
- Published applications
- 1,795
- Assignees
- 760
- Inventors
- 4,431
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1993 | 1 | 0 |
| 1994 | 1 | 0 |
| 1995 | 1 | 0 |
| 1996 | 1 | 0 |
| 1997 | 6 | 0 |
| 1998 | 8 | 0 |
| 1999 | 7 | 0 |
| 2000 | 11 | 0 |
| 2001 | 9 | 4 |
| 2002 | 12 | 15 |
| 2003 | 12 | 50 |
| 2004 | 35 | 77 |
| 2005 | 9 | 32 |
| 2006 | 58 | 39 |
| 2007 | 15 | 27 |
| 2008 | 24 | 34 |
| 2009 | 16 | 39 |
| 2010 | 13 | 41 |
| 2011 | 15 | 42 |
| 2012 | 18 | 52 |
| 2013 | 29 | 70 |
| 2014 | 59 | 96 |
| 2015 | 65 | 95 |
| 2016 | 71 | 107 |
| 2017 | 82 | 121 |
| 2018 | 77 | 86 |
| 2019 | 61 | 88 |
| 2020 | 59 | 99 |
| 2021 | 55 | 90 |
| 2022 | 52 | 104 |
| 2023 | 42 | 91 |
| 2024 | 39 | 96 |
| 2025 | 46 | 102 |
| 2026 | 28 | 98 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Small molecule inhibitors of viral replication6 Oct 2026US 12,751,963 B2The Trustees of Princeton University
- PAI-1 inhibitors and uses thereof15 Sep 2026US 12,735,402 B2The Cleveland Clinic Foundation
- Soft chewable veterinary dosage form1 Sep 2026US 12,721,839 B2Intervet Inc.
- Bacterial DNA gyrase inhibitors and methods of use thereof25 Aug 2026US 12,714,692 B2The Florida International University Board of Trustees
- Biphenyl sulfonamide compounds for the treatment of kidney diseases or disorders25 Aug 2026US 12,714,697 B2Travere Therapeutics, Inc.
- Combination therapy for pulmonary hypertension8 Oct 2026US 2026/0306461 A1Vivus, Inc.
- Non-Peptide Small Molecule FGF14:Nav1.6 Channel Complex Protein-Protein Interaction Modulators1 Oct 2026US 2026/0297027 A1Board of Regents, The University of Texas System
- Compounds for treating cancer1 Oct 2026US 2026/0297066 A1Genesis Molecular AI, Inc.
- Cyclic vinyl sulfone wrn inhibitors1 Oct 2026US 2026/0297070 A1Nimbus Wadjet, Inc.
- Oxazole trpml1 agonists and uses thereof1 Oct 2026US 2026/0297104 A1Libra Therapeutics, Inc.
Most cited
By later US patents
- Inhibitors of IMPDH enzyme190US 5,807,876 AVertex Pharmaceuticals Incorporated · 1998
- Pharmaceutical composition containing acid addition salt of basic drug163US 6,255,502 B1Farmarc Nederland BV · 2001
- Small organic molecule regulators of cell proliferation162US 6,613,798 B1Curis, Inc. · 2003
- Pyrazole compound and medicinal composition containing the same142US 7,429,609 B2Eisai R&D Management Co., Ltd. · 2008
- Thiazoles and oxazoles useful as modulators of ATP-binding cassette transporters130US 7,846,951 B2Vertex Pharmaceuticals Incorporated · 2010